Capital World Investors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Capital World Investors's AMGN Position: Q2 2026 in Review
Capital World Investors reduced its Amgen (AMGN) stake by 0.73% in Q2 2026, selling an estimated $72.9M and leaving 29,075,329 shares worth $10.5B. The position accounts for 1.24% of the portfolio, ranked #18.
Capital World Investors first reported a position in AMGN in Q2 2014 and has held it in 27 quarters since. 3,150 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Capital World Investors held 29,075,329 shares of Amgen worth $10.5B as of Q2 2026.
- Capital World Investors sold 213,014 Amgen shares in Q2 2026, an estimated $72.9M.
- Amgen made up 1.24% of Capital World Investors's portfolio in Q2 2026, its #18 holding.
- Capital World Investors first reported a position in Amgen in Q2 2014 and has held it in 27 quarters since.
- 3,150 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.